To ascertain whether adenosine produced by the FRβ+CD39+CD73+ Mφ subset is implicated in control of joint inflammation, we treated the collagen II-immunized DBA/1JRj mice before arthritis onset (starting day 14 and then every 3–4 days) with the folate antagonist MTX. The gene discussed is NT5E; the disease is arthritic joint disease.